» Articles » PMID: 11807799

Family History and the Risk of Stomach Cancer Death in Japan: Differences by Age and Gender

Overview
Journal Int J Cancer
Specialty Oncology
Date 2002 Jan 25
PMID 11807799
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Familial aggregation of stomach cancer has long been observed. The effect on disease risk of family history and its magnitude according to the type of affected relatives, however, is not well known. We conducted a prospective analysis using the JACC study (Japan Collaborative Cohort Study For Evaluation of Cancer Risk, sponsored by Monbusho) data. During the follow-up period, 662 stomach cancer deaths were documented. A positive history of stomach cancer in one or more first-degree relatives was associated with a significantly increased risk of death from the disease in both men (RR 1.60; 95% CI 1.11-2.31) and women (RR 2.47; 95% CI 1.50-4.06). In the subanalysis stratified by age, the association between positive family history and stomach cancer was stronger in the age group from 40-59 (RR 2.62; 95% CI 1.34-5.11 for men and RR 5.88; 95% CI 2.70-12.82 for women) than in the age group from 60-79 (RR 1.31; 95% CI 0.84-2.05 for men and RR 1.44; 95% CI 0.72-2.88 for women). In the age group from 40-59, men with father's history and women with mother's and sister's history of the disease had a significantly increased risk (RR 3.14; 95% CI 1.51-6.55, RR 10.46; 95% CI 4.54-24.12, RR 13.39; 95% CI 3.89-46.12, respectively). When 2 or more family members were affected, the increment in the risk was prominent especially in women (RR 9.45; 95% CI 4.46-20.05). These results suggest the existence of a certain subtype of stomach cancer that is inherited more often by women from one generation to the next in gender-influenced fashion. Any preventive strategy should take into account the degree of individual susceptibility.

Citing Articles

Family History and Gastric Cancer Risk: A Pooled Investigation in the Stomach Cancer Pooling (STOP) Project Consortium.

Vitelli-Storelli F, Rubin-Garcia M, Pelucchi C, Benavente Y, Bonzi R, Rota M Cancers (Basel). 2021; 13(15).

PMID: 34359744 PMC: 8345354. DOI: 10.3390/cancers13153844.


Family History and Risk of Upper Gastrointestinal Cancer in the Linxian General Population.

Yang H, Wang J, Zhang J, Fan J, Qiao Y, Taylor P Front Oncol. 2021; 11:605106.

PMID: 34123779 PMC: 8193945. DOI: 10.3389/fonc.2021.605106.


Clinicopathologic Characteristics and Long-Term Outcome of Gastric Cancer Patients with Family History: Seven-Year Follow-Up Study for Korean Health Check-Up Subjects.

Lee J, Chung S, Choi J, Han Y, Kim J Gastroenterol Res Pract. 2020; 2020:4028136.

PMID: 33144855 PMC: 7599414. DOI: 10.1155/2020/4028136.


Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric Cancers.

Chaudhary S, Kwak E, Hwang K, Lennerz J, Corcoran R, Heist R Oncologist. 2020; 25(11):e1691-e1700.

PMID: 32820577 PMC: 7648344. DOI: 10.1634/theoncologist.2020-0274.


Hereditary diffuse gastric cancer in two families: A case report.

Feroce I, Serrano D, Biffi R, Andreoni B, Galimberti V, Sonzogni A Oncol Lett. 2017; 14(2):1671-1674.

PMID: 28789394 PMC: 5529793. DOI: 10.3892/ol.2017.6354.